Strategic acquisitions Solabia is pursuing aggressive expansion through acquisitions, notably Mibelle Biochemistry and Xebios Diagnostics, signaling opportunities to cross-sell integrated cosmetic actives, nutraceutical ingredients, and microbiology diagnostics solutions to a broader customer base.

Cosmetics to life-science With activities spanning cosmetics, pharmacy, nutrition, biotechnology and microbiological diagnosis, there is potential to upsell across these adjacent markets by offering high-value natural actives, plant extracts, and diagnostic credentials to existing cosmetic and pharma clients.

Microbiology strengths Recent partnerships and asset acquisitions in microbiology and diagnostics indicate demand for microbiology solutions; position Solabia as a one-stop provider for microbiological testing, in vitro diagnostics, and related active ingredients to accelerate customer R&D.

CSR and sustainability Strong emphasis on CSR and sustainable development can be leveraged to target brands prioritizing ESG criteria, enabling co-development of responsible, environmentally friendly actives and validated supply-chain credentials appealing to premium cosmetic and pharma customers.

Digital and global reach Diverse tech stack and international R&D footprint suggest readiness for digital collaboration, data-driven formulation, and global partnerships; offer cloud-enabled platform access for formulation, compliance, and supply-chain transparency to multinational customers.